“Darnitsa” negotiates with big foreign companies about partnership – Shymkiv
Photo: Dmytro Shymkiv / Facebook
Head of Executive Board of the Managing Company of the PrJSC “Pharmaceutical firm “Darnitsa” Dmytro Shymkiv didn’t name the potential partners, but said that those were companies not only from Europe, but also from other regions.
PrJSC “Pharmaceutical firm “Darnitsa” (Kyiv) leads negotiations about strategic partnership with big foreign companies, Dmytro Shymkiv, head of Executive Board of the Managing Company of the PrJSC “Pharmaceutical firm “Darnitsa” supervisory board said in an interview with the Investory News.
“We are currently in the negotiation process with many companies, considering mostly big businesses. We are very ambitious, aiming for a synergy, enlargement of our pharmaceuticals portfolio, extensive growth, companies that provide opportunity of entering different markets,” he said
Shymkiv didn’t name the potential partners, but said that those were companies not only from Europe, but also from other regions. He also said that Darnitsa considers possible purchase of foreign companies.
“We are running at full speed. There’s no time to wait. Nowadays we are forming the executive board, leading negotiations with the investment companies, banks, and potential partners. We are predicting interesting deals in 2019,” Darnitsa’s top-manager said.
Shymkiv also said that in 2019 “Darnitsa” intends to switch over to electronic document flow, using the standards of world pharmaceutical industry. He added that “Darnitsa” invests 10 percent of its gross income in innovations, constantly growing the investments.
“After that we are going to reform our executive board. This is a long process. We know who we want to attract, but this takes time,” he said.
In an interview Shymkiv pointed out that he has no intentions to return into politics for now, and plans to stay on the current position in “Darnitsa” for at least several more years.
PrJSC “Pharmaceutical firm “Darnitsa” was founded in 1930. The company is a leading producer of pharmaceuticals by volume in Ukraine. Company’s portfolio includes more than 250 names of medical products.
In 2018 “Darnitsa” increased its net profit by 31, 3 percent, to 449,134 million UAH, and clear income from sales of products – by 18,7 percent, to 3,002 billion UAH.
The Zagoriy family, including the Verkhovna Rada lawmaker Glib Zagoriy, is the ultimate beneficiary of the company.
Dmytro Shymkiv used to work as a deputy head of the Presidential Administration of Ukraine from 2014 until 2018. Before that he headed the Ukrainian branch of Microsoft Corporation.